Clinical and Experimental Studies on Micro - Residual Leukemia Treatedwith Fuzheng Yiai （Resistance -supporting Tumor- inhibiting） Infusion Coordinated with Radiotherapy,

doi:10.13288/j.11-2166/r.1996.09.019

您当前的位置：

首页 >

文章列表页 >

Clinical and Experimental Studies on Micro - Residual Leukemia Treatedwith Fuzheng Yiai （Resistance -supporting Tumor- inhibiting） Infusion Coordinated with Radiotherapy,

更新时间：2021-11-22

- Clinical and Experimental Studies on Micro - Residual Leukemia Treatedwith Fuzheng Yiai （Resistance -supporting Tumor- inhibiting） Infusion Coordinated with Radiotherapy,
- Journal of Traditional Chinese Medicine Issue 9, Pages: 535-538(1996)
- 作者机构：
  
  1. 中国中医研究院西苑医院
  2. 山西化工厂医院
  3. 哈尔滨市血液病研究所
  4. 大同市中医院现在航天部医院
  5. 北京玉泉路,100039
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.1996.09.019
  CLC： R733.7
- Published：1996
- 稿件说明：
移动端阅览
[1]王乙忠,周霭祥,王志平,展昭明,马军,郭晓峰.扶正抑癌冲剂配合化疗治疗微小残留白血病的临床与实验研究[J].中医杂志,1996(09):535-538+516.

Clinical and Experimental Studies on Micro - Residual Leukemia Treatedwith Fuzheng Yiai （Resistance -supporting Tumor- inhibiting） Infusion Coordinated with Radiotherapy,[J]. Journal of Traditional Chinese Medicine1996, (9): 535-538.
[1]王乙忠,周霭祥,王志平,展昭明,马军,郭晓峰.扶正抑癌冲剂配合化疗治疗微小残留白血病的临床与实验研究[J].中医杂志,1996(09):535-538+516. DOI： 10.13288/j.11-2166/r.1996.09.019.

Clinical and Experimental Studies on Micro - Residual Leukemia Treatedwith Fuzheng Yiai （Resistance -supporting Tumor- inhibiting） Infusion Coordinated with Radiotherapy,[J]. Journal of Traditional Chinese Medicine1996, (9): 535-538. DOI： 10.13288/j.11-2166/r.1996.09.019.

摘要

扶正抑癌冲剂是治疗微小残留白血病（MRL）的有效药物

治疗后患者全身状况及并发症有明显的改善

该方显著提高MRL患者的免疫功能

提高完全缓解率及生存质量

延长患者生存期。对DNA指数、DNA非整倍体率、Ph’染色体、BCR/ABL基因等各项指标研究表明

该方具有抑制或消除恶性克隆的作用。体外细胞培养证实

本方具有刺激正常骨髓细胞增殖作用

但对白血病细胞无刺激作用。动物实验表明

该方可明显延长MRL动物模型的生存期。

Abstract

Fuzheng Yiai Infusion is an effective remedy for micro - residual leukemia （MRL）. It yields marked mitigation on the geneval condition of the patient and prevents complications by substantially improves the patients immunity

elevates the rate of total remission and living quality

prolongs the survival period. Studies on the indices including DNA index

rate of DNA non - uneuploid

ph’ chromosome

and BCR/ ABL gene

showed that the recipe can inhibit or eliminate the actions of malignant clone. In vitro cultivation of cells proved that the recipe yields stimulating action on the proliferation of normal marrow cells

yet yields no stimulating action on leukemic cells. Animal experiments reveal this recipe markedly prolongs the survival period of MRL animal models.

关键词

Keywords

references

查看原文

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

WANG Qingguo's Experience in Treatment of Headache Based on the Concept of "Achieving Harmony by Unblocking and Balancing"

Challenges and Recommendations for Implementing Key Technologies in Decentralized Clinical Trials of Traditional Chinese Medicine

Differentiation and Treatment of Small Cell Lung Cancer from the Perspective of "Internal Wind in Hidden Circulation"

Construction and Application of a Real-World Cohort of Community-Acquired Pneumonia Based on a Multimodal Large-Scale Traditional Chinese Medicine Big Data Platform

Construction and Application of "Source-Pivot-Convergence" Pattern Identification and Treatment Model for Malignant Tumors

Related Author

No data

Related Institution

No data

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰